Stable Supply

Home > Stable Supply > Stable Supply

Stable Supply

Towa achieves stable and speedy supply of drugs with a well-established production system and Towa Direct Sales System.
Stable supply is one of the aims of ethical drug manufacturers. Towa has 3 plants cooperating with each other for their backup systems and thus it can achieve stable supplies even if the operations stop at 1 of the plants.
Furthermore, Towa has established Towa Direct Sales System. This system assigns sales offices and agents all over Japan to provide quick services and maintain close contact with our customers.

Stable Production with 3 Plants

To guarantee stable supply, Towa is planning to formulate a backup system that will enable production of the same products in any plants. Towa is currently building the capacity to produce a total of 7.5 billion tablets across 3 plants.
Osaka Plant
Yamagata Plant
Okayama Plant

Medical Representatives (MRs) are Responsible for Their Sales in Towa Direct Sales System.

Generic drugs offered by Towa are characterized not only by their affordable prices but also by value-added products. Towa communicates these advantages to medical professionals, so they can effectively use them. In "Towa Direct Sales System" our MRs who belong to our sales offices and agents throughout Japan directly visit medical professionals and provide information together with products. Through this system, the MRs can swiftly provide feedback about the demands of the medical professionals to our business units. Towa will further strengthen this system by opening new sales offices. By increasing the number of our delivery staff, Towa will strengthen its system to achieve a secure and stable supply and maintain a close contact with our customers.
[Concept Chart of Towa Direct Sales System]


Home > Stable Supply > Stable Supply
© Copyright TOWA PHARMACEUTICAL CO.,LTD. All Rights Reserved.